Find your path to Philipp
505 people in our graph share verified history with Philipp — schools, employers, funds. One of them is your warm intro.
Ashley MarshallunlockedPhilipp: together at Patch.com (2011)
×8Philipp: together at University of California, Berkeley
Philipp: together at IndieBio
Philipp: together at The University of Hong Kong
About
Philipp Sander is an Investment Analyst at SOSV SF, where he focuses on therapeutics and human health companies. He began at SOSV as a venture fellow scouting new companies and now supports portfolio companies with business development, partnering strategy, indication selection, and technical work. He holds a PhD in Chemical Biology from the Scripps Research Institute in San Diego, with a background spanning engineered biology, medicinal chemistry, and biophysics.
Invests in
BiotechDigital HealthHealthtech
Experience
- SOSVInvestorcurrent2024 — presentSan Francisco Bay Area
- SOSVVenture Fellowcurrent2022 — presentSan Francisco Bay Area
- TippingPoint BiosciencesBoard Observercurrent2026 — present
- TippingPoint BiosciencesAdvisorcurrent2023 — present
- OncoPrecisionBoard Observercurrent2025 — present
- IndieBioVenture Fellow and beyondcurrent2022 — present
- RyboDyn Inc.Investor & Advisorcurrent2023 — present
- ReactosomeInvestor & Advisorcurrent2023 — present
- Stream GenomicsInvestor & Advisorcurrent2023 — present
- VIAN TherapeuticsInvestor & Advisorcurrent2023 — present
- The Scripps Research InstituteGraduate Student Researcher2017 — 2024Greater San Diego Area
- University of FreiburgMaster's Student2016 — 2017Freiburg Area, Germany
- University of Freiburg, Department of Internal Medicine IScientific Editor and Grant Writer2015 — 2017Freiburg, Baden-Württemberg, Germany
- University of California, BerkeleyVisiting Graduate Student2015 — 2016Berkeley, CA
- The University of BonnBachelor's Student2014Bonn Area, Germany
- The University of Hong KongResearch Intern2013 — 2014Hong Kong
- Patch.comWriter and Photographer2011Los Angeles Metropolitan Area
Skills & more
Due Diligence2Venture Capital1Protein Biochemistry2Molecular Biology4Optical Spectroscopy1Flow Cytometry1Protein Purification2Protein Expression3Organic Synthesis1Bioorganic Chemistry1Mammalian Cell Culture1Genome Editing1
+10 more
Chemical BiologyBiochemistryCell BiologyWestern BlottingAssay DevelopmentSDS-PAGEFluorescence MicroscopyNucleic Acid BiochemistryNon-Linear SpectroscopyCell Line EngineeringLanguages English · German
From Philipp's professional profile.
Colleagues at SOSV
Frequently asked questions
- Who is Philipp Sander?
- Philipp Sander is an Investment Analyst at SOSV SF, where he focuses on therapeutics and human health companies. He began at SOSV as a venture fellow scouting new companies and now supports portfolio companies with business development, partnering strategy, indication selection, and technical work. He holds a PhD in Chemical Biology from the Scripps Research Institute in San Diego, with a background spanning engineered biology, medicinal chemistry, and biophysics.
- Where does Philipp Sander work?
- Philipp Sander is Investment Analyst at SOSV.
- What does Philipp Sander invest in?
- Philipp Sander invests in Biotech, Digital Health, Healthtech.
- What check size does Philipp Sander write?
- Philipp Sander typically writes checks of $275K – $2M.
- Where did Philipp Sander go to school?
- Philipp Sander studied at Scripps Research (Doctor of Philosophy - PhD, Chemical Biology); The University of Freiburg (Master's degree, Biochemistry & Biophysics); The University of Hong Kong (BSc (Exchange), Biochemistry).
Same school
Also attended Scripps Research20
Venkat ReddyChief Science Officer at GENERAL INCEPTIONMarc MoesserInvestment Manager at redalpineKaushik RamInvestments at Yali CapitalMegan BlewettPrincipal at Scion Life SciencesElliot WarnerAssociate at Scion Life SciencesOdile RundquistPartner IR&BD at Bioqube Ventures
+ 14 more
Also attended The University of Freiburg66
Ruth Foxe BladerInvestor at Citrine VentureDr. Elias Börgmann-DehinaGeneral Counsel & Portfolio Manager at HeadlineJens LapinskiFounding Partner at Angel InvestChristina UlardicPartner at Astanor VenturesMaik FechnerVenture Partner at Blockchain Founders CapitalJan BeckerInvestment Team at 10x Founders
+ 60 more
Also attended The University of Hong Kong163
Roni HiranandInvestor at GV (Google Ventures)Anshul RuparellVenture Partner at FJ LabsJohan AkessonAssociate at Marlin Equity PartnersFan WenPrincipal & Director of AI at Fin CapitalJenny XiaoPartner at Leonis CapitalGéraldine FilletSenior Associate at Educapital
+ 157 more
Also attended The University of Bonn49
Miriam UeberallTuring Labs AI; Ex-R&D at Flora Food Group, Kraft Heinz, Unilever at PeakBridge VCJörg BinnenbrückerManaging Partner at CapnamicStella PaffenholzSenior Associate at Atlas VentureLennart SchlegelManager Investor Relations at FoodLabsChristophe WagnerInterim CFO at FoodLabsPetra KurschatTeam Manager at Seed+Speed
+ 43 more
Shared employers
Also worked at The Scripps Research Institute39
Jay ParrishVenture Partner at ARCH Venture PartnersJamie BacherEntrepreneur-In-Residence at The Innovation SpaceDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesVenkat ReddyChief Science Officer at GENERAL INCEPTIONLaure BouchezExecutives in Residence at GENERAL INCEPTIONElisabeth GardinerStrategic Advisor at GENERAL INCEPTION
+ 33 more
Also worked at University of Freiburg2
Also worked at University of California, Berkeley466
Ali GhodsiCo-founder & CEO of DatabricksRaquel UrtasunFounder & CEO of WaabiArhaan A.Deeptech Fellow at Clear VenturesKevin Wijayaインドネシア法人代表 (Indonesia Office Representative) at CyberAgent CapitalPaul JennyBoard Chair at CincyTechMichael PerezDeputy General Counsel at Mucker Capital
+ 460 more
Also worked at The University of Bonn5
Lennart SchlegelManager Investor Relations at FoodLabsJulia SeeligerInvestment Associate at European Circular Bioeconomy FundSanat MishraFounder at BioStack PlatformsSri Teja MullapudiPrincipal, Fund Investments, Scientific Lead at NoeticDamia TormoPresident, CEO, Treasurer and Founder at Artax Biopharma






































%20(2).png)














